Alchemab Therapeutics raised €69M in a Series A round in Apr 2021. The company is based in London, UK. Investors in the round: RA Capital Management. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
